Clemens M. Doppler
Président chez 4SC AG
Profil
Clemens M.
Doppler is currently the Chairman-Supervisory Board at 4SC AG since 2014.
He is also the Chairman at MerLion Pharmaceuticals Pte Ltd., Chairman-Supervisory Board at MerLion Pharmaceuticals GmbH, Director at Merlion Trade GmbH, Managing Director at Heidelbergcapital General Partner GmbH since 2008, Managing Partner at HeidelbergCapital Asset Management GmbH since 2008, Member at DVFA e.V., and Member-Supervisory Board at Verinos Pharmaceuticals GmbH.
In his former positions, Dr. Doppler served as the Chairman at Accovion GmbH from 2008 to 2015.
He was also the Vice Chairman-Supervisory Board at Sensovation AG from 2001 to 2013.
Additionally, he worked as the Business Development Director & Head-department at Phoenix International Life Sciences, Inc. from 1994 to 2000, and as the Director-Business Development & Head-department at Phoenix International Life Sciences, Inc. (Switzerland) during the same period.
Furthermore, he held the position of Investment Manager at 3i Group Plc from 2000 to 2007.
He also served as an Investment Manager at Technologie Holding and as a Member-Supervisory Board at vasopharm GmbH and Nanogate SE.
Dr. Doppler obtained his graduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.
Postes actifs de Clemens M. Doppler
| Sociétés | Poste | Début |
|---|---|---|
| 4SC AG | Président | 19/09/2014 |
| MerLion Pharmaceuticals GmbH | Président | - |
| Merlion Trade GmbH | Directeur/Membre du Conseil | - |
| Heidelbergcapital General Partner GmbH | Directeur Général | 01/01/2008 |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Président | 01/01/2006 |
| DVFA e.V. | Corporate Officer/Principal | - |
HeidelbergCapital Asset Management GmbH
 HeidelbergCapital Asset Management GmbH Investment ManagersFinance HeidelbergCapital Asset Management GmbH (HCAM) is an independent private equity firm established in 2007 with backing from New York-based private equity investor Auda International, controlled by the Harald Quandt family. HCAM is located in Heidelberg in southwestern Germany. The firm specializes in private equity secondaries. | Private Equity Investor | 01/01/2008 |
| Verinos Pharmaceuticals GmbH | Directeur/Membre du Conseil | - |
Anciens postes connus de Clemens M. Doppler
| Sociétés | Poste | Fin |
|---|---|---|
Accovion GmbH
 Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Accovion GmbH operates as a contract research organization, which offers planning and conducting of clinical drug tests, data collection, and processing. It also provides services in the areas of design, analysis, and creation of statistical and clinical reports. The firm also specializes in biometrical planning and evaluation, pharmaco-economic studies, as well as quality control and assurance. The company was founded on May 22, 2001 and is headquartered in Eschborn, Germany. | Président | 01/01/2015 |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Clemens M. Doppler
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| 4SC AG | Health Technology |
| 3I GROUP PLC | Finance |
| Entreprise privées | 14 |
|---|---|
Sensovation AG
 Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Sensovation AG manufactures and supplies scientific imaging instrumentation products. The firm specializes in the development and production of scientific imaging and low light detection solutions, based on charge coupled device and complementary metal oxide semiconductor technologies. It offers automated digital microscopes, microarray analyzers, and scientific cameras for bioimaging, diagnostics, and quality control in clean technology applications. It also engages in partnerships focused on building and supplying commercial production systems and platforms. The company was founded by Stefan Bickert and Paul Hing in 2000 and is headquartered in Radolfzell, Germany. | Electronic Technology |
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
HeidelbergCapital Asset Management GmbH
HeidelbergCapital Asset Management GmbH Investment ManagersFinance HeidelbergCapital Asset Management GmbH (HCAM) is an independent private equity firm established in 2007 with backing from New York-based private equity investor Auda International, controlled by the Harald Quandt family. HCAM is located in Heidelberg in southwestern Germany. The firm specializes in private equity secondaries. | Finance |
Nanogate SE
 Nanogate SE Industrial MachineryProducer Manufacturing Nanogate SE develops and produces nano composites and formulations. The company was founded by Ralf-Michael Zastrau in 1999 and is headquartered in Goettelborn, Germany. | Producer Manufacturing |
Accovion GmbH
Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Accovion GmbH operates as a contract research organization, which offers planning and conducting of clinical drug tests, data collection, and processing. It also provides services in the areas of design, analysis, and creation of statistical and clinical reports. The firm also specializes in biometrical planning and evaluation, pharmaco-economic studies, as well as quality control and assurance. The company was founded on May 22, 2001 and is headquartered in Eschborn, Germany. | Commercial Services |
| DVFA e.V. | |
| Heidelbergcapital General Partner GmbH | |
Phoenix International Life Sciences, Inc.
 Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Phoenix International Life Sciences, Inc. is a Canadian company that provides bioanalytical research and clinical testing services. The company is based in Saint-Laurent, Canada. Phoenix International Life Sciences was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 22, 2000 for $236.74 million. | Commercial Services |
| Phoenix International Life Sciences,Inc. (Switzerland) | |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
| Technologie Holding | Finance |
| Merlion Trade GmbH | |
| MerLion Pharmaceuticals GmbH | |
| Verinos Pharmaceuticals GmbH |
